ANSI/AAMI PB70: Closing the Gap
Discussion during the recent AAMI meeting included the use of correct wording for these products. For example, there was general consensus to include head and boot covers, which are meant to provide liquid barrier protection, and to exclude head caps meant to contain hair and foot covers meant to keep the environment free of contamination. After the October 16 AAMI meeting, the task groups will be working on better clarifying the purpose, definitions, barrier level requirements, and critical areas throughout the entire document. Many agreed diagrams for each product type should be included in the informative section simila...
Source: MDDI - January 5, 2018 Category: Medical Devices Authors: Sarah Smit Tags: Regulatory and Compliance Source Type: news
The ‘ smart pill ’ market could be worth $3B by 2025 – meet the key players
The “smart pill” market is expected to nearly quadruple in value to $3 billion by 2025, according to Grand View Research. Driving this growth is an increasing demand for minimally-invasive procedures, as well as better patient monitoring capabilities. There are a number of players in the pharmaceutical and medtech arenas looking to stake a claim to the smart pill market. The companies are segmented into two groups – those developing capsules used for endoscopy and those creating connected, swallowable drug-tracking systems. Get the full story at our sister site, Drug Delivery Business News. The post The &...
Source: Mass Device - January 4, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Imaging Pharmaceuticals Research & Development Wall Street Beat CapsoVision etectrx Medtronic Olympus Proteus Digital Health Source Type: news
Study: Patient self-audits through mobile app match traditional evaluations
Adherence reports self-generated by bowel surgery patients through an engagement and care management app strongly agreed with those recorded more traditionally by clinical auditors, according to a study recently published in Surgical Endoscopy. (Source: mobihealthnews)
Source: mobihealthnews - December 21, 2017 Category: Information Technology Source Type: news
PENTAX Medical Appoints Veteran Executive As The Americas Region President And CEO
MONTVALE, N.J., Dec. 21, 2017 -- (Healthcare Sales & Marketing Network) -- PENTAX Medical, a healthcare industry leader in endoscopy solutions, announced that David Woods, the current Global Chief Marketing Officer of PENTAX Medical, has been appointed Pr... Devices, Gastroenterology, Personnel PENTAX Medical, endoscope, endoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 21, 2017 Category: Pharmaceuticals Source Type: news
Two surgical approaches equal in treating infection-caused hydrocephalus
(Penn State) Implanting a shunt or endoscopically reducing intracranial pressure and reducing fluid production are equally effective in treating infants with hydrocephalus caused by brain infections, according to an international team of researchers, but endoscopy may have fewer down-the-line complications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 20, 2017 Category: International Medicine & Public Health Source Type: news
Mauritius:Health Minister Inaugurates Gastrointestinal Endoscopy Unit At Jeetoo Hospital
[Government of Mauritius] Government is determined to provide quality services to all citizens by placing health care at the core of its agenda with the priority of making the latest medical technology accessible to all. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 19, 2017 Category: African Health Source Type: news
Mauna Kea wins expanded FDA 510(k) for Cellvizio
Mauna Kea (ENT:MKEA) said today it won expanded FDA 510(k) clearance for its Cellvizio confocal laser endomicroscopy platform and its Confocal Miniprobe devices. The Cellvizio device is designed for use in a variety of surgical procedures, providing real time visualization at the microscopic level. The system allows the operating physician to visualize the internal microstructure of tissue in real time during ureteroscopic and cytoscopic procedures, Mauna Kea said. With the expanded clearance, the device is now indicated for identification of cells and vessels and their organizations and architecture, the Paris-b...
Source: Mass Device - December 18, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Imaging Regulatory/Compliance Mauna Kea Technologies Source Type: news
Medtronic Scoops Up an Irish Endoscopy Diagnostics Player
Medtronic has added two endoscopic devices to its portfolio through an acquisition that could be worth up to $45 million, according to various media reports. The new acquisition, Galway, Ireland-based Crospon, provides Medtronic with a functional luminal imaging probe called the Endoflip. The device consists of a balloon catheter that is inserted into the area being measured and injected with a conductive solution to enable electrodes in the balloon to record voltage. The Endoflip builds up a picture of the geometry of the esophagus, pylorus, and anal sphincters using high-resolution impedance planimetry, according to Cros...
Source: MDDI - December 11, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Medical Device Business Imaging Source Type: news
Report: Medtronic acquires gastro diag dev Crospon in deal worth $45m
Medtronic (NYSE:MDT) has reportedly acquired gastrointestinal disorder diagnostic company Crospon in a deal that could be worth as much as $45 million (EU €38 million), according to a Times UK report. The Galway, Ireland-based developer was founded in 2006 by current chief exec John O’Dea, and is looking to develop tools to more effectively examine and possibly treat gastrointestinal disorders, according to the report. The company produces endoscopic diagnostics, including its recently FDA-cleared Endoflip system, which includes the company’s Flip topography module designed to allow for the assessment...
Source: Mass Device - December 11, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics Mergers & Acquisitions Crospon Medtronic Source Type: news
Case series: treating cannabinoid hyperemesis syndrome with capsaicin cream
3 out of 5 stars Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series. Dezieck L et al. Clin Toxicol 2017 Sep;55:908-913. Abstract Cannabis hyperemesis syndrome (CHS) is a form of cyclic vomiting characterized by: chronic marijuana use recurrent vomiting, and lack of alternate explanation for symptoms A striking feature is that although CHS-induced nausea and vomiting are frequently resistant to standard antiemetics such as ondansetron, patients often report that very hot showers or baths relieve their symptoms. Several years ago, Jeff Lapoint ...
Source: The Poison Review - December 5, 2017 Category: Toxicology Authors: Leon Gussow Tags: Medical cannabinoid hyperemesis syndrome capsaicin treatment TRPV1 receptor Source Type: news
Quality Standards in Upper Gastrointestinal Endoscopy Quality Standards in Upper Gastrointestinal Endoscopy
This position statement presents the minimum expected standards in diagnostic upper gastrointestinal endoscopy, with a focus on technical competence and procedural safety.Gut (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 5, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Prepared for the unexpected: How Henri beat C. diff
Henri and his sister, Lucienne From the time he was born, Henri has been very reactive — to everything. As a baby, he was allergic to milk and soy, which led to weeping eczema all over his body. His allergies meant frequent ear infections and sinus infections. As a toddler, he was anemic and underweight. He had two urinary tract infections (UTIs) with fevers. At age 3, he had a circumcision because of the repeated UTIs. At age 4, a sinus infection spread to his eye orbit. Every sunscreen on the market gave him (and still gives him) a rash. At age 5, a bug bite on his ear led to a cartilage infection that required ant...
Source: Thrive, Children's Hospital Boston - November 29, 2017 Category: Pediatrics Authors: Marie Vedder Tags: Diseases & Conditions Our Patients’ Stories C-diff fecal transplant gastroenterology Lori Zimmerman Sonia Ballal Source Type: news
$1.3M project seeks to move endoscopy rooms to new ambulatory surgery center
Kernersville Endoscopy Center has filed a request with the state to move two gastrointestinal endoscopy rooms from a location in Winston-Salem to a new ambulatory surgery center in Kernersville. The project, which would shift the rooms from the Piedmont Endoscopy Center, would cost more than $1.3 million, according to the certificate-of-need application. Kernersville Endoscopy said in its application that the project is not competitive and has asked for expedited review. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 22, 2017 Category: American Health Authors: Jessica Seaman Source Type: news
Mucosal healing: An objective measure of disease activity?
(Boston University School of Medicine) The absence of inflammatory and ulcerative lesions in all segments of the colon, also known as mucosal healing, should be the end goal in treating patients with ulcerative colitis according to an editorial in the journal Gastrointestinal Endoscopy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 21, 2017 Category: International Medicine & Public Health Source Type: news
Endoscopy Could Spare More Barrett's Patients From Surgery Endoscopy Could Spare More Barrett's Patients From Surgery
For patients with Barrett's esophagus, endoscopy, a recognized treatment for high-grade dysplasia, is just as effective for intramucosal carcinoma, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Report from groundbreaking 'EndoVators Summit' offers guidance for obesity treatment
(American Society for Gastrointestinal Endoscopy) A recently published white paper from the American Society for Gastrointestinal Endoscopy and the Association for Bariatric Endoscopy breaks new ground in defining the role and value of the latest approaches for obesity management. The paper reports on the scope and impact of the obesity problem as well as the multiple factors and players involved in treating this chronic condition. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 9, 2017 Category: International Medicine & Public Health Source Type: news
7 medtech stories we missed this week: Nov. 3, 2017
[Image from unsplash.com]From Hologic’s new product launch to CapsoVision gettting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Hologic launches new MyoSure device Hologic announced in a Nov. 1 press release that it has launched its MyoSure Manual Device in the U.S. The device is designed to help doctors resect and remove intrauterine tissue easily in an office setting if used with the MyoSure hysteroscope. 2. IntraFuse wins FDA clearance for FlexThread fibula pin IntraFuse has received FDA 510(k) clearance for its FlexThread Fibula Pin System, ...
Source: Mass Device - November 3, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Endoscopic / Arthroscopic Oncology Orthopedics Pain Management Regulatory/Compliance Surgical Ultrasound Women's Health brhmedical CapsoVision Helomics Hologic Inc. IntraFuse MedTech Sensus Healthcare LLC Skyline Med Source Type: news
Ambu pays $261m for Invendo Medical
Ambu (CPH:AMBU-B) this week said it agreed to put $261 million on the table for Invendo Medical and its line of disposable endoscopy devices. Copenhagen-based Ambu said it paid $133.2 million (€115 million) up front for Invendo, with another $127.4 million (€110 million) in possible milestones. Those include a $81.1 million (€70 million) payment pegged to FDA clearances and $46.3 million (€40 million) in earnouts over four years. Some $11.6 million (€10 million) is expected to come due this fiscal year after Invendo wins 510(k) clearance from the FDA for the next iteration of its HD colon...
Source: Mass Device - October 27, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Hospital Care Mergers & Acquisitions Wall Street Beat Ambu Invendo Medical Source Type: news
Olympus Announces Continued Expansion of Its GI Endoscopic Device Line with ESD Innovations
SB Knives, Eleview and Guardian Driving Complete Solutions for Gastroenterologists CENTER VALLEY, Pa., Oct. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technology leader in designing and delivering innovative solutions for m... Devices, Gastroenterology, Product Launch Olympus Medical Systems, EndoTherapy, endoscopy, Submucosal Dissection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 13, 2017 Category: Pharmaceuticals Source Type: news
New studies add to understanding of treatments for Barrett's esophagus
(American Society for Gastrointestinal Endoscopy) The October issue of GIE: Gastrointestinal Endoscopy features several new studies evaluating various treatments for Barrett's esophagus (BE). BE is a condition in which there are unusual changes to the cells lining the esophagus. It is believed to be most commonly due to inflammation from gastroesophageal reflux disease (GERD). Sometimes these changes may be considered precancerous. Endoscopic treatments for BE focus on removing or destroying the problematic tissue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 6, 2017 Category: Cancer & Oncology Source Type: news
Olympus launches joint Sony-developed Orbeye 4K-3D video microscope
Olympus (TYO:7733) said today it launched its Orbeye 4K-3D video microscope developed by Sony Olympus Medical solutions, a joint venture between Olympus and Sony‘s (TYO:6758) Imaging Products & Solutions biz. The company said the Orbeye microscope is designed to provide high-resolution 3D imaging of the structure of tissue, blood vessels and other features to enable more accurate surgery. The system includes a 55-inch display to allow for simultaneous surgical team viewing. “The Orbeye exoscope represents the next generation of operative imaging- a true quantum shift. Its adoption is certain and w...
Source: Mass Device - October 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Olympus Sony Corp. Source Type: news
MM-24 Series Medical-Grade Monitors feature rear VESA mount holes.
MM-24 Series Medical-Grade Monitors come with 24 in. screen with a HD resolution of 1920 x 1080. Units are integrated with VGA, HDMI, DisplayPort and DVI video inputs and are available with internal or external Medical-Grade power supplies. Products offer viewing angle of 178 in. x 178 in. and are suitable for medical carts in ICU’s, and endoscopy and medical system applications. Monitors are offered with boom arms, table top bases, wall and ceiling mounts.This story is related to the following:Health, Medical,& Dental Supplies and EquipmentSearch for suppliers of:Patient Monitoring Equipment (Source: Industr...
Source: Industrial Newsroom - Health, Medical and Dental Supplies - October 3, 2017 Category: Medical Devices Source Type: news
The Human Experience: How Patients Inspire Innovation and Why Medtech Should Listen
Discussions centered on patient-centered, outward-looking technology with an emphasis on data and patient engagement. The medtech CEO, physician, and hospital executive all consider innovation differently, but they all have the patient as the muse. What Patient-Inspired Innovation Means Todd Dunn, innovation director for Intermountain Healthcare, said during a conference panel that his organization created a new initiative to put empathy at the forefront of innovation. He said Proctor & Gamble's "immersion research," where executives spend time in people's homes to understand what matters to them, inspired hi...
Source: MDDI - September 30, 2017 Category: Medical Devices Authors: Heather R. Johnson Tags: Medical Device Business Source Type: news
Boston Scientific launches third Connected Patient Challenge
Boston Scientific today announced the launch of its third annual Connected Patient Challenge, which it is holding in collaboration with Google and Medstro. The last competition was about big data, artificial intelligence and patient-engagement technologies. This time around, the competition is offering winners up to $50,000 in services to help them realize their big idea about how to use the Internet of Things to improve diagnosis, treatment, monitoring or patient care. The goal is to find IoT solutions in neuromodulation, cardiac rhythm management, cardiology, electrophysiology, peripheral interventions, oncolog...
Source: Mass Device - September 26, 2017 Category: Medical Devices Authors: Chris Newmarker Tags: Big Data Diagnostics Patient Monitoring Research & Development Boston Scientific Connected Patient Challenge google Google Inc. Medstro Source Type: news
More Post-endoscopy GI Bleeding With Warfarin Than Direct Oral Anticoagulants More Post-endoscopy GI Bleeding With Warfarin Than Direct Oral Anticoagulants
Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 21, 2017 Category: Surgery Tags: Gastroenterology News Source Type: news
Cook Medical parent company sells subsidiary for $950M
The parent company of Cook Medical, which operates an endoscopy division in Winston-Salem, has sold one of its subsidiary companies for $950 million. Cook Group announced Tuesday that it is selling Cook Pharmica, a privately held, biologics-focused contract development and manufacturing organization, to Somerset, N.J.-based Catalent for $750 million cash at closing and the remainder in four annual installments. The Winston-Salem facility, whic h focuses on medical device manufacturing, is wholly… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 20, 2017 Category: American Health Authors: Rebecca Troyer Source Type: news
Standards for Upper GI Endoscopy Released Standards for Upper GI Endoscopy Released
The BSG and AUGIS jointly released recommendations to improve the quality of upper gastrointestinal endoscopy and reduce the risk for missed early cancerous lesions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Pentax Medical wins CE Mark for DEC duodenoscope
Hoya‘s Pentax Medical said today it won CE Mark approval in the European Union for its DEC duodenoscope featuring a disposable elevator cup. The Tokyo-based company said the new device features a combination of advanced cleaning capabilities and improved infection prevention controls to ensure a more reliable performance. The new device also features improved high definition video quality. The DEC’s single-use, sterile, distal end cap was designed to reduce the likelihood of carbapenem-resistant Enterobacteriaceae infections which have been linked to duodenoscope devices. “The new DEC Duodensocope is...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Imaging Regulatory/Compliance Hoya Corp. Pentax Medical Source Type: news
Boston Scientific touts 3-year Alair follow-up study results
Boston Scientific (NYSE:BSX) today released 3-year follow-up cohort results from the post-FDA approved PAS2 clinical trial of its Alair system designed for bronchial thermoplasty to treat severe persistent asthma, touting reduced severe asthma attacks, hospitalizations and ER visits. Results from the trial were recently published in the European Respiratory Journal, the Marlborough, Mass.-based company said. The PAS2 trial is an open-label study which enrolled patients at 27 North American centers, with 95% of the recruited patients considered severe asthmatics. Boston Scientific said that data from the cohort co...
Source: Mass Device - September 18, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory Boston Scientific Source Type: news
Medtronic launches StealthStation ENT surgical navigation system
Medtronic (NYSE:MDT) said today it launched its StealthStation ENT surgical navigation system designed for otolaryngology procedures. The StealthStation ENT works by generating an electromagnetic field around the target patients’ anatomy during surgery so instrument positioning can be dynamically tracked, the Fridley, Minn.-based company said. “The intraoperative use of computer-aided surgery is very helpful to assist the surgeon in clarifying complex anatomy during sinus and skull base surgery. It provides an added level of assurance and may allow for a more thorough sinus procedure,” Dr. Joseph Rav...
Source: Mass Device - September 12, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Otolaryngology Ear, Nose & Throat Surgical Medtronic Source Type: news
Single photons pinpoint objects inside living tissue
Laser-based technique could improve endoscopy (Source: PhysicsWeb News)
Source: PhysicsWeb News - September 12, 2017 Category: Physics Authors: Edwin Cartlidge Source Type: news
Boston Scientific starts production at Malaysian plant
Boston Scientific (NYSE:BSX) this week launched operations at its Penang, Malaysia-based facilities, the medical device giant’s 1st Asian manufacturing facility, according to a report from The Edge Financial Daily. The 375,000 square foot facility, located in Batu Kawan Industrial Park in Penang, will undergo an official opening ceremony next February, according to the report. Boston Scientific has plans to add as many as 400 new local jobs at the facility over the next 2 years. The plant is designed to produce both cardiovascular and endoscopy products, with plans to expand into urology products in 2018, accord...
Source: Mass Device - September 11, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Boston Scientific Source Type: news
Duodenal Biopsies in Celiac Disease: Adhering to Guidance? Duodenal Biopsies in Celiac Disease: Adhering to Guidance?
Guidelines recommend taking at least four duodenal biopsy specimens at the time of upper GI endoscopy if celiac disease is suspected, but this study indicates some centers are falling short.BMJ Open Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 4, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Antibe Therapeutics Approved to Conduct Phase II Trial for ATB-346
Antibe Therapeutics has announced that it has received approval from Health Canada to initiate a Phase 2, double-blind, gastrointestinal endoscopy trial for its lead drug ATB-346. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 30, 2017 Category: Pharmaceuticals Source Type: news
Position Statement: Serrated Polyps in the Colon and Rectum Position Statement: Serrated Polyps in the Colon and Rectum
The British Society of Gastroenterology Endoscopy section presents a position statement providing clinical guidance on management of serrated polyps in the colon and rectum.Gut (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 24, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Cantel Medical closes $61m BHT buyout
Cantel Medical (NYSE:CMN) said today that it closed its $60.8 million acquisition of German endoscope reprocessor BHT Hygienetechnik Holding. Gersthofen, Germany-based BHT, which employs about 100 people, put up sales of abut $24.5 million last year, according to Little Falls, N.J.-based Cantel. “Establishing leadership in our international markets is a key component of our strategy and this milestone will help us achieve this goal. The addition of BHT Group will enable us to become the market leader in automated endoscope reprocessors in Germany. We’re excited to combine BHT’s expertise an...
Source: Mass Device - August 23, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Mergers & Acquisitions Wall Street Beat Cantel Medical Corp. Source Type: news
Britain's Creo Receives Speedy FDA Approval for Its Endoscopic Device Britain's Creo Receives Speedy FDA Approval for Its Endoscopic Device
Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 22, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Britain's Creo receives speedy FDA approval for its endoscopic device
LONDON (Reuters) - Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch. (Source: Reuters: Health)
Source: Reuters: Health - August 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news
7 medtech stories we missed this week: August 11, 2017
[Image from unsplash.com]From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its product line extensions for the Calix-C cervical inter body cages. The clearance allows for two larger footprints to be added for use with allograft. The Calix-C Cervical Interbody Spacer is designed for spinal fusion procedures at level one in patients who are skeletally m...
Source: Mass Device - August 11, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiovascular Clinical Trials Food & Drug Administration (FDA) Oncology Regulatory/Compliance Spinal Surgical Apifix Cardiac Science Hip Innovation Life Spine Inc. MedTech Pentax Medical Varian Medical Systems Xtant M Source Type: news
August GIE studies show promising results for patients with endoscopic treatments
(American Society for Gastrointestinal Endoscopy) The August issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE), features a study reporting that a simpler procedure for collecting biopsy specimens during various procedures can improve patient care, and a study showing how a relatively new procedure, POEM, has been adapted to help an additional set of patients with gastroparesis, a troubling stomach problem. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 3, 2017 Category: Cancer & Oncology Source Type: news
Surveillance Endoscopy in Hereditary Diffuse Gastric Cancer Surveillance Endoscopy in Hereditary Diffuse Gastric Cancer
Regular surveillance endoscopy may have value for patients with a family history of hereditary diffuse gastric cancer (HDGC), according to research.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - August 1, 2017 Category: Pathology Tags: Hematology-Oncology News Source Type: news
Cantel Medical to buy BHT Group for $60m
Cantel Medical (NYSE:CMN) said today it inked a definitive agreement to purchase German endoscope reprocessor BHT Hygienetechnik Holding for $60.8 million. BHT Group has approximately 100 employees and provides automated endoscope reprocessing alongside related equipment, services and flexible endoscope repairs, Little Falls N.J.-based Cantel Medical said. Over the past year, BHT Group reported revenues of $24.5 million. “Establishing leadership in our international markets is a key component of our strategy and this milestone will help us achieve this goal. The addition of BHT Group will enable us to become the...
Source: Mass Device - July 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Cantel Medical Corp. Source Type: news
Cogentix Medical buys UK-based Genesis Medical
Cogentix Medical (NSDQ:CGNT) said today it acquired London-based Genesis Medical for an undisclosed amount. Genesis Medical produces, sells and markets urology products in the U.K. and operated as the exclusive regional distributor for Cogentix’s PrimeSight endoscopy systems. Cogentix said it purchased all tangible assets of Genesis, and will pay up to an additional $671,560 (GBP £515,000) based on revenue milestones through March 2019. “The purchase of Genesis Medical is our second business development transaction this month and follows our announcement last week of an Endo-Urology product line laun...
Source: Mass Device - July 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Urology Cogentix Medical Source Type: news
Banks Receives American Gastroenterological Association ’s Mentoring Award
Peter Banks, MD, of the Division of Gastroenterology, Hepatology and Endoscopy, was honored with the 2017 Research Mentor Award from the Pancreatic Disorders Section of the American Gastroenterological Association at their annual meeting in May in Ch (Source: BWH News)
Source: BWH News - July 25, 2017 Category: Hospital Management Source Type: news
Allurion raises $27m in Series C for Elipse gastric balloon
Allurion Technologies said today it raised $27 million in a Series C round of funding to support its Elipse gastric balloon designed for weight loss. Allurion’s Elipse gastric balloon is made of a thin, flexible polymer film and is ingested as a capsule without the need for surgery. The balloon is filled once it reaches a patient’s stomach to reduce hunger, and passes naturally through the GI tract after 4 months. “The procedureless nature of the Elipse Balloon is a step forward in the field of weight loss devices. In my practice, there is an unmet need for weight loss options that do not require sur...
Source: Mass Device - July 11, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Weight loss Allurion Technologies Source Type: news
Pentax Medical, Aohua ink JV endoscopy deal
Hoya‘s Pentax Medical said today it inked a joint venture deal with Shanghai Aohua Photoelectricity to develop flexible medical endoscopy products. The new JV company will look to offer endoscopy solutions with an initial focus on “needs of emerging markets,” according to Tokyo-based Pentax. “With Pentax Medical as our partner, this joint venture provides Aohua with the immediate opportunity to reach more patients throughout the world,” Aohua CEO Dr. Xiaozhou Gu said in a prepared statement. “We have been committed to developing innovative technology, and our employees&rsq...
Source: Mass Device - July 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Endoscopic / Arthroscopic Hoya Corp. Pentax shanghaiaohuaphotoelectricity Source Type: news
PENTAX Medical and Aohua Establish Flexible Medical Endoscopy Joint Venture
TOKYO and SHANGHAI, July 6, 2017 -- (Healthcare Sales & Marketing Network) -- On July the 7th 2017 Tokyo time, PENTAX Medical (a division of HOYA Group) and Shanghai Aohua Photoelectricity Endoscope Co., Ltd. (AOHUA) today announced the creation of a join... Devices, Gastroenterology PENTAX Medical, HOYA Group, Aohua, endoscopy, flexible endoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 7, 2017 Category: Pharmaceuticals Source Type: news
Balloon, Spiral Endoscopy Similarly Effective for Small Bowel Diagnosis Balloon, Spiral Endoscopy Similarly Effective for Small Bowel Diagnosis
Balloon enteroscopy and spiral endoscopy are equally effective for diagnosing small bowel disorders, according to a new systematic review and meta-analysis.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 5, 2017 Category: Surgery Tags: Family Medicine/Primary Care News Source Type: news
Halyard Health taps former Acelity head Woody for CEO | Personnel Moves July 5, 2017
Halyard Health (NYSE:HYH) said late last month it tapped former Acelity prez & CEO Joseph Woody as its new chief executive officer, replacing a retiring Robert Abernathy. Woody will also assume a seat on the board of directors, with former CEO Abernathy continuing on as board chair, the Alpharetta, Ga.-based company said. “On behalf of the board and Halyard employees, we are grateful for Robert’s dedicated leadership these past three plus years. During his tenure, Robert re-established Halyard’s innovative culture and positioned the company for future growth. Halyard is successfully executing its...
Source: Mass Device - July 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Acelity Cardiovascular Systems Inc. Conventus Orthopaedics depuysynthes Halyard Health IsoRay johnsonandjohnson Lumicell Merck nevro Olympus personnel-moves Raumedic Sanofi-Aventis SOLOS Endoscopy Inc. Source Type: news